首页 › 基金 › Defilade Capital Management, L.P. › ENOV
Defilade Capital Management, L.P. 对 ENOV 的持仓历史
ENOVIS CORPORATION · 医疗保健
Defilade Capital Management, L.P. 在 Q3 2026 的 13F 申报中披露持有 ENOV(ENOVIS CORPORATION)399,651 股,市值约 US$7.3M,约占其申报组合的 1.22%,在其申报持仓中市值排名第 27 位。 Defilade Capital Management, L.P. 最近 2 个申报季度中有 2 个季度披露了 ENOV 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Defilade Capital Management, L.P. 对 ENOV 的持仓演变
Defilade Capital Management, L.P. 于 Q2 2026 首次披露 ENOV 持仓:531,945 股(约 US$11.0M)。 在 2 次申报中,Defilade Capital Management, L.P. 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 399,651 股、市值约 US$7.3M,环比减持 -132,294 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 531.95K | $11.01M | 新进 |
| Q3 2026 | 399.65K | $7.30M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ENOV 与 13F 数据
ENOV(ENOVIS CORPORATION)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 ENOV,申报仓位最大的包括:Rubric Capital Management LP (US$96.8M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PRIVATE MANAGEMENT GROUP INC (US$32.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ENOV 的基金
- Rubric Capital Management LP 5.30M 股 · $96.83M · Q3 2026
- OAKTREE CAPITAL MANAGEMENT LP 39.21M 股 · $37.79M · Q2 2026
- PRIVATE MANAGEMENT GROUP INC 1.79M 股 · $32.75M · Q3 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 1.66M 股 · $30.26M · Q3 2026
- Front Street Capital Management, Inc. 1.45M 股 · $26.48M · Q3 2026
- ARISTEIA CAPITAL, L.L.C. 25.43M 股 · $24.17M · Q3 2026
更多关于 Defilade Capital Management, L.P.
常见问题
How long has Defilade Capital Management, L.P. held ENOV?
Defilade Capital Management, L.P. has disclosed ENOV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Defilade Capital Management, L.P.'s current position in ENOV?
As of Q3 2026, Defilade Capital Management, L.P. holds 399.65K shares of ENOV (ENOVIS CORPORATION), valued at $7.30M, representing 1.22% of its reported portfolio and ranking #27.
Has Defilade Capital Management, L.P. been buying or selling ENOV?
In the latest 13F filing (Q3 2026), Defilade Capital Management, L.P. reduced its position in ENOV.
Which other funds hold ENOV?
Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PRIVATE MANAGEMENT GROUP INC, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.